Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Outcomes Research Study Article
This is a selection made from among articles on Drug Treatment Outcomes Research Study. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
A Gay Drug Rehab Component in a Heterosexual Drug Rehab: The Best Of Both Worlds
By Jonathan Huttner
Treatment Aspects of Inpatient Drug Rehab
Generally speaking, a drug rehab or alcohol rehab is best described as an inpatient addiction treatment facility specializing in the treatment of drug addiction, alcoholism and dual disorders. Most of the individuals that attend drug rehab go through detox initially, to be followed by the inpatient drug rehab portion of treatment which is clinically driven. Historically, everyone with a variety of disorders or sexual preferences are treated together and expected to adapt. I feel this philosophy is flawed and the expectation placed on patients might be unrealistic. In far too many cases, the issues patients bring into drug rehab or alcohol rehab far exceed their initial ability to just "fit in". This is especially true with gay drug addiction and issues such as; internalized homophobia, coming out, gay relationships and a host of others.
Is a Completely Gay Drug Rehab Best
As advances have been made in the area of gay addiction treatment and gay drug rehab, two distinct philosophies seem to have been adopted. The first is a drug rehab or alcohol rehab which is totally focused on treating the gay, lesbian population. This gay drug rehab only admits gays to addiction treatment. While this might prove beneficial for some segment of the gay population, it might not be realistic for others. Addiction treatment or drug rehab should resemble the real world and an entirely gay drug rehab is not the real world. It is not what the the recovering gay person will face after they are discharged from their gay drug rehab. They will be discharged into a predominantly heterosexual world and all the challenges associated with dealing with heterosexual prejudice, discrimination, homophobia etc.
The Benefits of a Gay Drug Rehab Component
The other philosophy of providing addiction treatment for the gay population in a drug or alcohol rehab lies in developing an gay addiction treatment component within the drug rehab. This provides the gay addict or alcoholic with group settings specific to their population allowing them a safer place to discuss intimate issues they are not yet ready to discuss with a heterosexual. On the other hand, they will still be encouraged to participate in more generalized clinical activities with the rest of the drug rehab community. This drug rehab design allows for the gay person a "safe space" where they will not feel judged and at the same time allow them to practice what they have learned in their groups. To take things a step further, it will also allow the heterosexual to practice recovery skills such as acceptance, unconditional love and honesty.
If you are looking to locate a quality gay drug rehab, gay alcohol rehab or addiction treatment program with a gay drug rehab component, you can go to http://www.recoveryconnection.org or call their national helpline 1-800-511-9225
Jonathan Huttner is a principal in Lakeview Health Systems, a drug rehab which specializes in the treament of drug addiction, alcoholism and dual diagnosis.
Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?A-Gay-Drug-Rehab-Component-in-a-Heterosexual-Drug-Rehab:-The-Best-Of-Both-Worlds&id=356902
Drug Treatment Outcomes Research Study Specific links
Drug Treatment Outcomes Research Study News
CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence ...
WOONSOCKET, R.I., May 23, 2012 /PRNewswire/ -- New research sponsored by CVS Caremark examined the effects of Food and Drug Administration (FDA) drug warnings on medication adherence when the warnings ...
Read more...Staggered Cancer Drug Delivery Better Than All In One Go
The fact that treating cancer patients with multiple drugs often results in better outcomes than a single drug treatment is long been known amongst the medical profession. However, a MIT study published in the May 11 issue of Cell has just demonstrated that the order and timing of administering drugs may also have a dramatic impact. The study revealed that staggering doses of erlotinib and ...
Read more...Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment for Atrial Fibrillation
Patients with the heart rhythm disorder atrial fibrillation who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.
Read more...4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
Over the course of two weeks, four people visited the MGUH for medical treatment due to mushroom (amantin) poisoning. One Virginia man arrived at MedStar Georgetown University Hospital (MGUH) in the early stages of liver failure after having mistakenly eaten poisonous mushrooms he handpicked from his yard. All four cases, including their clinical course, management and outcomes were presented at ...
Read more...HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
THURSDAY, May 3 (HealthDay News) -- The use of the anti-HIV drug tenofovir during pregnancy appears to be safe for infants, new research suggests.
Read more...J&J drug shows promise in high-risk prostate cancer
(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized ...
Read more...BG Medicine Announces Publication of First Study on Use of Galectin-3 in Selection of Drug Therapy in Heart Failure
WALTHAM, Mass. -- BG Medicine, Inc. , a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that results from a sub-study of the Controlled Rosuvastatin ...
Read more...Health Outcomes Liaisons Improve Drug Reimbursement with Preemptive Payer Communication
With greater economic pressures and more competition for many products, private and governmental payers require clear and thorough data to prove that a new treatment’s clinical benefits justify additional cost.
Read more...Study finds increase in maternal opiate use, infants born with drug withdrawal syndrome
( JAMA and Archives Journals ) Between 2000 and 2009 in the United States, the annual rate of maternal opiate use increased nearly five-fold, while diagnosis of the drug withdrawal syndrome among newborns, neonatal abstinence syndrome (NAS), increased almost three-fold, accompanied by a substantial increase in hospital charges related to NAS, according to a study published online by JAMA.
Read more...Hormone-depleting drug shows promise against localized high-risk prostate tumors
Researchers have demonstrated that a hormone-depleting drug approved for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a new clinical study.
Read more...